Izotropic Corporation (IZOZF)
USD 0.03
(-10.45%)
USD 0.03
(-10.45%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 15.3 Thousand CAD | 0.0% |
| 2023 | 55.7 Thousand CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 22.09 Thousand CAD | 0.0% |
| 2024 Q4 | 15.3 Thousand CAD | 0.0% |
| 2024 FY | 15.3 Thousand CAD | -72.53% |
| 2024 Q2 | 33.7 Thousand CAD | 0.0% |
| 2024 Q1 | 41.91 Thousand CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 Q3 | 66.46 Thousand CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2023 FY | 55.7 Thousand CAD | 0.0% |
| 2023 Q4 | 55.7 Thousand CAD | -16.2% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -155.0% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | 98.821% |
| Biocept, Inc. | 10.37 Million USD | 99.853% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 99.97% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.975% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 97.199% |
| iMD Companies, Inc. | 1.1 Million USD | 98.614% |
| IDenta Corp. | 428.17 Thousand USD | 96.427% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 99.639% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | 94.496% |
| NovelStem International Corp. | 3.32 Million USD | 99.54% |
| Optigenex Inc. | 4.42 Million USD | 99.654% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | 99.062% |
| Response Genetics, Inc | 4.91 Million USD | 99.689% |
| Rennova Health, Inc. | 359.19 Thousand USD | 95.74% |
| RushNet, Inc. | 4.25 Million USD | 99.64% |
| ScreenPro Security Inc. | 249.05 Thousand USD | 93.857% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | 98.084% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | 97.346% |
| Todos Medical Ltd. | 33 Million USD | 99.954% |